Cargando…
Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
INTRODUCTION: Use of triptans for acute treatment of migraine is associated with insufficient efficacy and/or tolerability in approximately 30–40% of people. We conducted a systematic literature review (SLR) to synthesize definitions, terminology, subsequent treatment outcomes, and characteristics a...
Autores principales: | Leroux, Elizabeth, Buchanan, Andrew, Lombard, Louise, Loo, Li Shen, Bridge, Daisy, Rousseau, Ben, Hopwood, Natasha, Matthews, Brandy R., Reuter, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595976/ https://www.ncbi.nlm.nih.gov/pubmed/32990921 http://dx.doi.org/10.1007/s12325-020-01494-9 |
Ejemplares similares
-
Lasmiditan for the acute treatment of migraine: Subgroup analyses by
prior response to triptans
por: Knievel, Kerry, et al.
Publicado: (2019) -
A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication
por: Lombard, Louise, et al.
Publicado: (2020) -
Comparison of healthcare resource utilization and costs among
patients with migraine with potentially adequate and insufficient triptan
response
por: Marcus, Steven C, et al.
Publicado: (2020) -
Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016) -
Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008)